EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA ‐ DQB1 *06:02 Allele

Antti-Mathias Taka iD, Taina Härkönen iD, Paula Vähäsalo iD, Tommi Vatanen iD, Johanna Lempainen iD, Riitta Veijola iD, Maaret Turtinen iD, Jorma Ilonen iD, Mikael Knip iD, Finnish Pediatric Diabetes Register

HLA · 2024

DOI: 10.1111/tan.15720 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift HLA, 2024. Verfasst von Antti-Mathias Taka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, HLA-DQ beta-Chains, Alleles, Haplotypes. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lastentautien Tutkimussäätiö, Medicinska Understödsföreningen Liv och Hälsa, Finska Läkaresällskapet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We set out to examine in an observational study characteristics of type 1 diabetes at the time of diagnosis among paediatric patients carrying the protective HLA class II DQB1*06:02 allele. We compared characteristics of type 1 diabetes among 5530 Finnish children aged 0–14 years diagnosed between 2003 and 2018. Seventy‐five children with type 1 diabetes carried the DQB1*06:02 allele. The carriers of DQB1*06:02 allele were compared to all children with type 1 diabetes without this allele and those with a high‐risk genotype. We also analysed, how does the genotype of a high‐risk haplotype paired with DQB1*06:02 affect the phenotype of patients with newly diagnosed type 1 diabetes. Carriers of the DQB1*06:02 allele were diagnosed at an older age than those with any other HLA class II genotype ( p = 0.003) or the high‐risk genotype ( p < 0.001). After adjusting the results for age and sex, no significant differences in clinical markers were observed. Glutamic acid decarboxylase autoantibody (GADA) levels were higher among carriers of DQB1*06:02 when compared to those with other genotypes ( p = 0.033). Having a high‐risk haplotype paired with DQB1*06:02 ‐positive haplotype was associated with higher levels of islet antigen 2 autoantibodies (IA‐2A) ( p < 0.001) and somewhat shorter duration of symptoms ( p = 0.043). The association between the protective DQB1*06:02 allele and an older age at diagnosis as well as higher levels of GADA at diagnosis of type 1 diabetes was confirmed. The effects of the DQB1*06:02 ‐positive haplotype seem to dominate when paired with a high‐risk haplotype.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HLA-DQ beta-ChainsAllelesHaplotypesHumansChildMaleFemaleChild, PreschoolAdolescentInfantGenetic Predisposition to DiseaseGenotypeInfant, NewbornFinlandAutoantibodiesGlutamate Decarboxylase

Stichwörter der Autor:innen

HLA genotypeautoantibodieschildrengenetic risktype 1 diabetes

Substanzen

HLA-DQ beta-ChainsHLA-DQB1 antigenAutoantibodiesGlutamate Decarboxylase

Autor:innen und Institutionen

  • Pediatric Research Center, New Children's Hospital, Helsinki University Hospital, Helsinki, Finland.
  • Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland.
  • Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
  • Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • Liggins Institute, University of Auckland, Auckland, New Zealand.

ORCID-Profile: Antti-Mathias Taka, Taina Härkönen, Paula Vähäsalo, Tommi Vatanen, Johanna Lempainen, Riitta Veijola, Maaret Turtinen, Jorma Ilonen, Mikael Knip

Förderung

  • Lastentautien Tutkimussäätiö
  • Medicinska Understödsföreningen Liv och Hälsa
  • Finska Läkaresällskapet

Zitieren

APA

Taka, A. M., Härkönen, T., Vähäsalo, P., Vatanen, T., Lempainen, J., Veijola, R., Turtinen, M., Ilonen, J., Knip, M., & Finnish Pediatric Diabetes Register (2024). Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA ‐ DQB1 *06:02 Allele. HLA. https://doi.org/10.1111/tan.15720

Vancouver

Taka AM, Härkönen T, Vähäsalo P, Vatanen T, Lempainen J, Veijola R, et al. Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA ‐ DQB1 *06:02 Allele. HLA. 2024. doi:10.1111/tan.15720

BibTeX
@article{Taka2024,
  author = {Taka, Antti-Mathias and Härkönen, Taina and Vähäsalo, Paula and Vatanen, Tommi and Lempainen, Johanna and Veijola, Riitta and Turtinen, Maaret and Ilonen, Jorma and Knip, Mikael and Finnish Pediatric Diabetes Register, Finnish Pediatric Diabetes Register},
  title = {Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA ‐ DQB1 *06:02 Allele},
  journal = {HLA},
  year = {2024},
  doi = {10.1111/tan.15720}
}
Kostenlos starten →